Zenotech Laboratories Ltd (532039):製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Zenotech Laboratories Ltd (532039) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C10114
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:18
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:インド
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Zenotech Laboratories Ltd (Zenotech) manufactures and markets generic biopharmaceuticals products. It classifies its products into two categories, namely, generic biopharmaceuticals and new biological. The company’s Generic biopharmaceuticals is further sub-divided into generic biological and generic chemicals. Its product portfolio includes G-CSF, G-MCSF and generic chemical oncology injectables. The company is specialty in generic injectables in the area of manufacturing Oncology, bio-technology and General Injectables products. The company markets its products in both domestic and international markets. It has subsidiaries in Nigeria, Brazil and the US. Zenotech is headquartered in Hyderabad, Telangana, India.

Zenotech Laboratories Ltd (532039) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Zenotech Laboratories Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Zenotech Laboratories Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Zenotech Laboratories Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Zenotech Laboratories Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Zenotech Laboratories Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Zenotech Laboratories Ltd, Pharmaceuticals & Healthcare, Deal Details 10
Equity Offering 10
Zenotech Labs to Raise Funds through Rights Offering 10
Zenotech Labs Plans to Raise up to USD17.6 Million in Rights Offering 11
Acquisition 12
Sun Pharma To Acquire 28.1% Stake In Zenotech Labs For US$3 Million 12
Zenotech Laboratories Ltd – Key Competitors 13
Zenotech Laboratories Ltd – Key Employees 14
Zenotech Laboratories Ltd – Locations And Subsidiaries 15
Head Office 15
Other Locations & Subsidiaries 15
Recent Developments 16
Corporate Communications 16
Feb 03, 2018: Zenotech Laboratories Appoints Mr. Rajendra Singh Parihar as CEO 16
Nov 21, 2017: Zenotech Laboratories: Resignation of Chief Executive officer of the company 17
Appendix 18
Methodology 18
About GlobalData 18
Contact Us 18
Disclaimer 18

List of Tables
Zenotech Laboratories Ltd, Pharmaceuticals & Healthcare, Key Facts, 2018 2
Zenotech Laboratories Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Zenotech Laboratories Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Zenotech Laboratories Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Zenotech Laboratories Ltd, Deals By Therapy Area, 2012 to YTD 2018 8
Zenotech Laboratories Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Zenotech Labs to Raise Funds through Rights Offering 10
Zenotech Labs Plans to Raise up to USD17.6 Million in Rights Offering 11
Sun Pharma To Acquire 28.1% Stake In Zenotech Labs For US$3 Million 12
Zenotech Laboratories Ltd, Key Competitors 13
Zenotech Laboratories Ltd, Key Employees 14
Zenotech Laboratories Ltd, Subsidiaries 15

List of Figures
Zenotech Laboratories Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Zenotech Laboratories Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Zenotech Laboratories Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Zenotech Laboratories Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Zenotech Laboratories Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Zenotech Laboratories Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Zenotech Laboratories Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Zenotech Laboratories Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[Zenotech Laboratories Ltd (532039):製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • The Tata Power Co Ltd:発電所・企業SWOT分析
    The Tata Power Co Ltd - Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key employe …
  • LeMaitre Vascular Inc (LMAT):製品パイプライン分析
    Summary LeMaitre Vascular Inc (LeMaitre Vascular) is a medical device company. It undertakes the development, manufacture, marketing and sale of devices that are used in the treatment of peripheral vascular diseases. The company offers several product lines for vascular surgery and endovascular proc …
  • Trican Well Service Ltd (TCW):石油・ガス:M&Aディール及び事業提携情報
    Summary Trican Well Service Ltd (Trican) is an oilfield services company, which provides specialized products, equipment, services and technology for use in the drilling, completion, stimulation and reworking of oil and gas wells. Its specialized services comprise fracturing, cementing, coiled tubin …
  • Organogenesis Inc:医療機器:M&Aディール及び事業提携情報
    Summary Organogenesis Inc (Organogenesis) is a regenerative medicine company that operates in the areas of bioactive wound healing and soft tissue regeneration. The company’s products include apligraf and dermagraft. Its dermagraft is used for the treatment of full-thickness diabetic foot ulcers. Or …
  • Skyworks Solutions Inc (SWKS):企業の財務・戦略的SWOT分析
    Skyworks Solutions Inc (SWKS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • Andhra Petrochemicals Ltd (500012)
    Andhra Petrochemicals Ltd (500012) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company
  • Prism Medical Ltd:医療機器:M&Aディール及び事業提携情報
    Summary Prism Medical Ltd (Prism Medical), a subsidiary of Handicare AB is a medical device company that manufacturer and provides durable medical equipment. The company offers products such as fixed ceiling lifts, portable ceiling lifts, portable track systems, mobile floor lifts, sling systems, ho …
  • Mobile Telesystems:企業のM&A・事業提携・投資動向
    Mobile Telesystems - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Mobile Telesystems Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), d …
  • Sembcorp Industries Ltd (U96)-エネルギー分野:企業M&A・提携分析
    Summary Sembcorp Industries Limited (Sembcorp) is a diversified energy, water and marine company. The company’s utilities division provides energy and water to industrial and municipal customers. Its energy operations include power generation, steam production and supply and natural gas import suppl …
  • Chongqing Taiji Industry (Group) Co Ltd (600129):製薬・医療:M&Aディール及び事業提携情報
    Summary Chongqing Taiji Industry (Group) Co Ltd (Chongqing Taiji) is a provider of generic products. The company offers products such as traditional Chinese medicine, hospital products, OTC products, base products, and dietary supplement. It provides research and development, equipment, and manageme …
  • Rolta India Ltd (ROLTA):企業の財務・戦略的SWOT分析
    Rolta India Ltd (ROLTA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • Holland America Line Inc:企業の戦略的SWOT分析
    Holland America Line Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products a …
  • Aileron Therapeutics Inc (ALRN)-製薬・医療分野:企業M&A・提携分析
    Summary Aileron Therapeutics Inc (Aileron) is a biopharmaceutical company that develops and commercializes novel class of therapeutics. The company provides products such as stapled peptide drugs. Its stapled peptides penetrate cells throughout the body and modulate intracellular protein-protein int …
  • The McClatchy Company (MNI):企業の財務・戦略的SWOT分析
    The McClatchy Company (MNI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • WCCT Global Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary WCCT Global Inc (WCCT Global) is a contract research organization that offers early drug development and late phase CRO services. The organization provides CRO solutions, clinical development and clinical support services. Its CRO solutions include project management, clinical monitoring, ph …
  • The Boston Beer Company, Inc.:企業の戦略・SWOT・財務分析
    The Boston Beer Company, Inc. - Strategy, SWOT and Corporate Finance Report Summary The Boston Beer Company, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • ImmunoGen Inc (IMGN):企業の財務・戦略的SWOT分析
    ImmunoGen Inc (IMGN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Evercore Inc:企業のM&A・事業提携・投資動向
    Evercore Inc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Evercore Inc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, …
  • PPG Industries Inc (PPG):企業の財務・戦略的SWOT分析
    PPG Industries Inc (PPG) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Claris Lifesciences Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary Claris Lifesciences Ltd (Claris) is a manufacturer of generic drugs and pharmaceutical products. The company provides generic drugs that are directly injected into the human body, which is mainly used in the treatment of critical illnesses. It provides products are offered through various de …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆